Introduction: Epilepsy affects 65 million people globally, with drug-resistant epilepsy (DRE) developing in 30% of patients. Neuromodulation therapies, such as deep brain stimulation (DBS), responsive neurostimulation (RNS), and ... ...

请注册登录后继续浏览